NCT00395109

Brief Summary

Patients with head and neck cancer will be imaged with PET scan and CT scan in order to determine areas of the tumour that are hypoxic. It is hypothesized that PET /CT will provide information on hypoxia of the tumors and tumor regions in head and neck cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at P50-P75 for early_phase_1 head-and-neck-cancer

Timeline
Completed

Started Nov 2006

Typical duration for early_phase_1 head-and-neck-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 2, 2006

Completed
6 days until next milestone

Study Start

First participant enrolled

November 8, 2006

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2009

Completed
Last Updated

August 28, 2017

Status Verified

August 1, 2017

Enrollment Period

3.1 years

First QC Date

November 1, 2006

Last Update Submit

August 25, 2017

Conditions

Keywords

cancerhypoxiaPET scanCT scan

Outcome Measures

Primary Outcomes (2)

  • FDG/PET visualization of glycolysis/blood flow in tumors and intra-tumor regions;

    2 years

  • Measurement of mRNAs levels encoding hypoxia response genes in tumor samples.

    2 years

Interventions

PET/CTDEVICE

All study participates will be scanned with PET/CT scan before surgery.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with head and neck tumours (\>3cm diameter) without bone involvement.

You may not qualify if:

  • Known allergy to contrast agents
  • Poor kidney function (serum creatinine level \> 2.0 mg/dL or 177 mmol/L)
  • Pregnancy
  • Breast-feeding
  • Unable to lie supine
  • Patient who were biopsied or operated upon within the past month.
  • Patient who were treated with chemotherapy or radiation within the past month.
  • Tumors that were obscured by artifacts (e.g. tooth fillings) in CT scans.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Science Center

London, Ontario, N6A 5W9, Canada

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsNeoplasmsHypoxia

Interventions

Positron Emission Tomography Computed Tomography

Condition Hierarchy (Ancestors)

Neoplasms by SiteSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Positron-Emission TomographyTomography, Emission-ComputedImage Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography, X-Ray ComputedMultimodal ImagingRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayRadionuclide ImagingTomographyDiagnostic Techniques, Radioisotope

Study Officials

  • John Yoo, MD

    Dept. of Otolaryngology, London Health Science Center, London, Ontario, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2006

First Posted

November 2, 2006

Study Start

November 8, 2006

Primary Completion

November 30, 2009

Study Completion

December 31, 2009

Last Updated

August 28, 2017

Record last verified: 2017-08

Locations